Department of Medicine, Division of General Internal Medicine and Division of Hospital Medicine, University of Colorado, Aurora, Colorado, USA.
Department of Internal Medicine, Dell Medical School at The University of Texas at Austin, Austin, Texas, USA.
J Hosp Med. 2022 Sep;17(9):679-692. doi: 10.1002/jhm.12908. Epub 2022 Jul 26.
Hospitalizations related to the consequences of opioid use are rising. National guidelines directing in-hospital opioid use disorder (OUD) management do not exist. OUD treatment guidelines intended for other treatment settings could inform in-hospital OUD management.
Evaluate the quality and content of existing guidelines for OUD treatment and management.
OVID MEDLINE, PubMed, Ovid PsychINFO, EBSCOhost CINHAL, ERCI Guidelines Trust, websites of relevant societies and advocacy organizations, and selected international search engines.
Guidelines published between January 2010 to June 2020 addressing OUD treatment, opioid withdrawal management, opioid overdose prevention, and care transitions among adults.
We assessed quality using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument.
Nineteen guidelines met the selection criteria. Most recommendations were based on observational studies or expert consensus. Guidelines recommended the use of nonstigmatizing language among patients with OUD; to assess patients with unhealthy opioid use for OUD using the Diagnostic Statistical Manual of Diseases-5th Edition criteria; use of methadone or buprenorphine to treat OUD and opioid withdrawal; use of multimodal, nonopioid therapy, and when needed, short-acting opioid analgesics in addition to buprenorphine or methadone, for acute pain management; ensuring linkage to ongoing methadone or buprenorphine treatment; referring patients to psychosocial treatment; and ensuring access to naloxone for opioid overdose reversal.
Included guidelines were informed by studies with various levels of rigor and quality. Future research should systematically study buprenorphine and methadone initiation and titration among people using fentanyl and people with pain, especially during hospitalization.
与阿片类药物使用后果相关的住院治疗呈上升趋势。目前不存在指导医院内阿片类药物使用障碍(OUD)管理的国家指南。旨在用于其他治疗环境的 OUD 治疗指南可能为医院内 OUD 管理提供信息。
评估现有的 OUD 治疗和管理指南的质量和内容。
OVID MEDLINE、PubMed、Ovid PsychINFO、EBSCOhost CINHAL、ERCI 指南信托、相关学会和倡导组织的网站以及选定的国际搜索引擎。
2010 年 1 月至 2020 年 6 月期间发布的、针对成人 OUD 治疗、阿片类药物戒断管理、阿片类药物过量预防以及护理交接的指南。
我们使用评估研究和评估指南(AGREE)II 工具评估质量。
19 项指南符合入选标准。大多数建议基于观察性研究或专家共识。指南建议在 OUD 患者中使用非污名化语言;使用《疾病和相关健康问题统计分类-第 5 版》(DSM-5)标准评估患有不健康阿片类药物使用的患者是否患有 OUD;使用美沙酮或丁丙诺啡治疗 OUD 和阿片类药物戒断;在急性疼痛管理中使用多模式、非阿片类药物疗法,并在需要时,除丁丙诺啡或美沙酮外,还可使用短期阿片类药物镇痛药;确保与持续的美沙酮或丁丙诺啡治疗相联系;将患者转介至心理社会治疗;并确保获得纳洛酮用于阿片类药物过量逆转。
纳入的指南受到了不同严格程度和质量的研究的启发。未来的研究应系统地研究芬太尼使用者和疼痛患者(尤其是在住院期间)的丁丙诺啡和美沙酮起始和滴定。